Structure and dynamics of intercalation complexes of anthracyclines with d(CGATCG)2 and d(CGTACG)2. 2D-1H and 31P NMR investigations

Journal of the Chemical Society. Perkin Transactions 2

Volumn , Issue 9, 1998, Pages 1983-1991

  Mazzini, Stefania ^a   Mondelli, Rosanna ^a   Ragg, Enzio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000162440     PISSN: 03009580     EISSN: None     Source Type: Journal    
DOI: 10.1039/a802350f     Document Type: Article

References (45)

1. (a) F. Arcamone, Doxorubicin: Anticancer Antibiotics, New York, Academic Press, 1981;
2. (b) S. Penco and F. Arcamone, Molecular aspects of anticancer drug action, ed. J. W. Lown, Macmillan Press, London, 1988;
3. (c) R. D. Anderson, M. L. Veigl, J. Baxter and W. D. Sedwick, Cancer Res., 1991, 51, 3930.
4. (a) E. M. Acton, G. L. Tong, C. W. Mosher and R. L. Wolgemuth, J. Med. Chem., 1984, 27, 638;
5. (b) A. Bargiotti, P. Zini, S. Penco and F. Giuliani, US Pat., 4 672 057, 1987;
6. (c) N. Komeshima, H. Kawai, S. Nakajima, M. Watanabe, T. Tsurno, T. Takeuchi and N. Otake, J. Antibiot., 1989, 42, 1425.
7. (a) J. Westendorf, M. Aydin, G. Groth, O. Weller and H. Marquardt, Cancer Res., 1989, 49, 5262;
8. (b) M. Grandi, G. Pezzoni, D. Ballinari, L. Capolongo, A. Suarato, A. Bargiotti, D. Faiardi and F. Spreafico, Cancer Treat. Rev., 1990, 17, 133;
9. (c) P. A. Vasey, D. Bisset, M. Strolin-Benedetti, I. Poggesi, M. Breda, L. Adams, P. Wilson, M. A. Pacciarini, S. B. Kaye and J. Cassidy, Cancer Res., 1995, 55, 2090.
10. (a) S. Neidle and M. Waring, Molecular Aspects of Anticancer Drug-DNA Interactions, Macmillan Press, London, 1993;
11. (b) W. B. Pratt, R. W. Ruddon, W. D. Ensminger and J. Maybaum, The Anticancer Drugs, Oxford University Press, London, 1994;
12. (c) G. Capranico, E. Butelli and F. Zunino, Cancer Res., 1995, 55, 312.
13. (a) C. Cullinane, S. M. Cutts, A. van Rosmalen and D. R. Phillips, Nucleic Acids Res., 1994, 22, 2296;
14. (b) C. Cullinane and D. R. Phillips, Biochemistry, 1994, 33, 6207.
15. F. Leng, R. Savkur, I. Fokt, T. Przewloka, W. Priebe and J. B. Chaires, J. Am. Chem. Soc., 1996, 118, 4731.
16. B. Pullman, Anti-Cancer Drug Des., 1991, 7, 95.
17. (a) J. M. Neumann, J. A. Cavailles, M. Herve, S. Tran-Dinh, B. Langlois d'Estaintot, T. Huynh-Dinh and J. Igolen, FEBS Lett., 1985, 182, 360;
18. (b) J. B. Chaires, K. R. Fox, J. E. Herrera, M. Britt and M. J. Waring, Biochemistry, 1987, 26, 8227;
19. (c) V. Rizzo, C. Battistini, A. Vigevani, N. Sacchi, G. Rozzano, F. Arcamone, A. Garbesi, F. P. Colonna, M. Capobianco and L. Tondelli, J. Mol. Recognit., 1989, 2, 132.
20. (a) E. Ragg, R. Mondelli, C. Battistini, A. Garbesi and F. P. Colonna, FEBS Lett., 1988, 236, 231;
21. (b) R. Bortolini, S. Mazzini, R. Mondelli, E. Ragg, C. Ulbricht, S. Vioglio and S. Penco, Appl. Magn. Reson., 1994, 7, 71.
22. (a) A. H. J. Wang, G. Ughetto, G. J. Quigley and A. Rich, Biochemistry, 1987, 26, 1152;
23. (b) M. H. Moore, W. N. Hunter, B. Langlois d'Estaintot and O. Kennard, J. Mol. Biol., 1989, 206, 693;
24. (c) A. Frederick, L. D. Williams, G. Ughetto, G. A. van der Marel, J. H. van Boom, A. Rich and A. H. J. Wang, Biochemistry, 1990, 29, 2538;
25. (d) Y. G. Gao and A. H. J. Wang, Anti-Cancer Drug Des., 1991, 6, 137.
26. (a) M. Cirilli, F. Bachechi, G. Ughetto, F. P. Colonna and M. L. Capobianco, J. Mol. Biol., 1992, 230, 878;
27. (b) Y. G. Gao and A. H. J. Wang, J. Biomol. Struct. Dyn., 1995, 13, 103.
28. (a) C. Odefey, J. Westendorf, T. Dieckmann and H. Oschkinat, Chem. Biol. Interact., 1992, 85, 117;
29. (b) J. Igarashi and M. Sunagawa, Bioorg. Med. Chem. Lett., 1995, 5, 2923.
30. H. Chen and D. J. Patel, J. Am. Chem. Soc., 1995, 117, 5901.
31. (a) L. Braunschweiler and R. R. Ernst, J. Magn. Reson., 1983, 53, 521;
32. (b) A. Bax and D. G. Davis, J. Magn. Reson., 1985, 65, 355;
33. (c) V. Sklenàr and A. Bax, J. Magn. Reson., 1987, 74, 469;
34. (d) A. Bax, R. H. Griffey and B. L. Hawkins, J. Magn. Reson., 1983, 55, 301;
35. (e) M. R. Bendall, D. T. Pegg and D. M. Doddrell, J. Magn. Reson., 1983, 52, 81.
36. S. J. Weiner, P. A. Kollman, D. A. Case, U. C. Singh, C. Ghio, G. Alagona, S. Jr. Profeta and P. Weiner, J. Am. Chem. Soc., 1984, 106, 756.
37. (a) J. W. Lown, C. C. Hanstock, R. C. Bleackley, J. L. Imbach, B. Rayner and J. J. Vasseur, Nucleic Acids Res., 1984, 12, 2519;
38. (b) L. Nilsson, G. M. Clore, A. M. Gronenborn, A. T. Brünger and M. Karplus, J. Mol. Biol., 1986, 188, 455;
39. (c) M. Delepierre, T. Huynh Dihn and B. P. Proques, Biopolymers, 1989, 28, 2115.
40. (a) D. G. Gorenstein, Phosphorus-31 NMR. Principles and Applications, Academic Press, New York, 1984;
41. (b) D. G. Gorenstein, Chem. Rev., 1994, 94, 1315 and references cited therein.
42. K. Wutrich, NMR of Proteins and Nucleic Acids, Wiley, New York, 1986.
43. (a) R. Mondelli, E. Ragg, G. Fronza and A. Arnone, J. Chem. Soc., Perkin Trans. 2, 1987, 15;
44. (b) R. Mondelli, E. Ragg and G. Fronza, J. Chem. Soc., Perkin Trans. 2, 1987, 27.
45. W. Saenger, Principles of Nucleic Acid Structure, Springer-Verlag, New York, 1984 and references cited therein.